Home
Contact
Links
PsiOxus Therapeutics
/
Links
Comments are closed.
PsiOxus in the News
PsiOxus Upcoming Events
PsiOxus Awards & Achievements
Recent Posts
PsiOxus Therapeutics Announces Clinical Trial with Third Cancer Gene Therapy Treatment and Appointment of New Chief Medical Officer
PsiOxus Therapeutics Announces First-in-Human Dosing of their Second Gene Therapy Cancer Treatment.
PsiOxus Therapeutics to Collaborate with the Parker Institute for Cancer Immunotherapy
PsiOxus Therapeutics Receives $15 Million Milestone Payment as Armed Oncolytic Virus Licensed to Bristol-Myers Squibb Achieves CTA
PsiOxus Therapeutics is listed in FierceBiotech’s 2017 Fierce 15
Filter Publications
Enadenotucirev Preclinical
Enadenotucirev Clinical
T-SIGn
Reviews
© Copyright 2020 PsiOxus Therapeutics
RSS
Back to Top
About
Vision & Strategy
People & Investors
Partnering
Recruitment Opportunities
Awards & Achievements
Pipeline
Pipeline
Enadenotucirev
T-SIGn Platform
NG-348
NG-350A
NG-641
Publications
Clinical Trials
News & Events
PsiOxus in the News
Contact
Menu
Comments are closed.